抄録
A new catalytic system was developed for the direct catalytic asymmetric aldol reaction of thioamides. The new lithium-free Cu catalyst (second-generation catalyst) exhibited enhanced catalytic efficiency over the previously developed catalyst comprising [Cu(CH3CN) 4]PF6/Ph-BPE/LiOAr (first-generation catalyst), which required a tedious catalyst preparation process. In the reaction with the second-generation catalyst, the intermediate Cu-aldolate functioned as a Brønsted base to generate thioamide enolate, efficiently driving the catalytic cycle. The present aldol methodology culminated in a concise asymmetric synthesis of atorvastatin (Lipitor®: atorvastatin calcium), a widely prescribed HMG-CoA reductase inhibitor for lowering low-density lipoprotein cholesterol.
本文言語 | English |
---|---|
ページ(範囲) | 6539-6546 |
ページ数 | 8 |
ジャーナル | Tetrahedron |
巻 | 67 |
号 | 35 |
DOI | |
出版ステータス | Published - 2011 9月 2 |
外部発表 | はい |
ASJC Scopus subject areas
- 生化学
- 創薬
- 有機化学